Skip to search.
 TSX Down 0.40% TSX Ventures Up 0.34%

Merck & Co. Inc. (MRK)

-NYSE
57.60 Down 0.66(1.13%) Mar 26, 4:02PM EDT
|After Hours : 57.75 Up 0.15 (0.26%) Mar 26, 7:37PM EDT
Add to Portfolio
Prev Close:58.26
Open:58.04
Bid:57.60 x 200
Ask:58.19 x 800
1y Target Est:63.77
Beta:0.43
Next Earnings Date:28-Apr-15MRK Earnings announcement
Day's Range:57.41 - 58.20
52wk Range:52.49 - 63.62
Volume:10,582,936
Avg Vol (3m):11,344,900
Market Cap:163.48B
P/E (ttm):14.15
EPS (ttm):4.07
Div & Yield:1.80 (3.10%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
MRKDown 1.13%163.48B
GSKDown 1.46%112.24B
NVSDown 0.80%238.81B
PFEDown 0.41%209.36B

Key Statistics

Forward P/E (1 yr):15.12
P/S (ttm):3.91
Ex-Dividend Date:12-Mar-15

Analysts

Annual EPS Est (Dec-15) :3.38
Quarterly EPS Est (Mar-15) :0.75
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):3.56

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Merck & Co., Inc. provides health care solutions worldwide. The company offer therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infec... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback